[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Biologics and Biosimilars Market Report 2018

February 2018 | 112 pages | ID: UE7172BEC29EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Biologics and Biosimilars market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Biologics and Biosimilars in these regions, from 2013 to 2025 (forecast).
United States Biologics and Biosimilars market competition by top manufacturers/players, with Biologics and Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
  • Merck
  • Lilly
  • 3sbio
  • Changchun High Tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Sandoz
  • Teva
  • Hospira
  • Mylan
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Antibiotic
  • Enzyme
  • Hormone
  • Non-Patented Biological Reagents
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Biologics and Biosimilars Market Report 2018

1 BIOLOGICS AND BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars by Product Category
  1.2.1 United States Biologics and Biosimilars Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Biologics and Biosimilars Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Antibiotic
  1.2.4 Enzyme
  1.2.5 Hormone
  1.2.6 Non-Patented Biological Reagents
  1.2.7 Other
1.3 United States Biologics and Biosimilars Market by Application/End Users
  1.3.1 United States Biologics and Biosimilars Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
  1.3.5 Hemophilia
  1.3.6 Other
1.4 United States Biologics and Biosimilars Market by Region
  1.4.1 United States Biologics and Biosimilars Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Biologics and Biosimilars Status and Prospect (2013-2025)
  1.4.3 Southwest Biologics and Biosimilars Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Biologics and Biosimilars Status and Prospect (2013-2025)
  1.4.5 New England Biologics and Biosimilars Status and Prospect (2013-2025)
  1.4.6 The South Biologics and Biosimilars Status and Prospect (2013-2025)
  1.4.7 The Midwest Biologics and Biosimilars Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Biologics and Biosimilars (2013-2025)
  1.5.1 United States Biologics and Biosimilars Sales and Growth Rate (2013-2025)
  1.5.2 United States Biologics and Biosimilars Revenue and Growth Rate (2013-2025)

2 UNITED STATES BIOLOGICS AND BIOSIMILARS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Biologics and Biosimilars Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Biologics and Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Biologics and Biosimilars Average Price by Players/Suppliers (2013-2018)
2.4 United States Biologics and Biosimilars Market Competitive Situation and Trends
  2.4.1 United States Biologics and Biosimilars Market Concentration Rate
  2.4.2 United States Biologics and Biosimilars Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIOLOGICS AND BIOSIMILARS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Biologics and Biosimilars Sales and Market Share by Region (2013-2018)
3.2 United States Biologics and Biosimilars Revenue and Market Share by Region (2013-2018)
3.3 United States Biologics and Biosimilars Price by Region (2013-2018)

4 UNITED STATES BIOLOGICS AND BIOSIMILARS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Biologics and Biosimilars Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
4.3 United States Biologics and Biosimilars Price by Type (2013-2018)
4.4 United States Biologics and Biosimilars Sales Growth Rate by Type (2013-2018)

5 UNITED STATES BIOLOGICS AND BIOSIMILARS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Biologics and Biosimilars Sales and Market Share by Application (2013-2018)
5.2 United States Biologics and Biosimilars Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOLOGICS AND BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biologics and Biosimilars Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 Biologics and Biosimilars Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Amgen
  6.3.2 Biologics and Biosimilars Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 AbbVie
  6.4.2 Biologics and Biosimilars Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Biologics and Biosimilars Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.2 Biologics and Biosimilars Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
  6.7.2 Biologics and Biosimilars Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Novartis
  6.8.2 Biologics and Biosimilars Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Merck
  6.9.2 Biologics and Biosimilars Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Lilly
  6.10.2 Biologics and Biosimilars Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 3sbio
6.12 Changchun High Tech
6.13 CP Guojian Pharmacy
6.14 Biotech Pharma
6.15 Gelgen Biopharma
6.16 Sandoz
6.17 Teva
6.18 Hospira
6.19 Mylan

7 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

7.1 Biologics and Biosimilars Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biologics and Biosimilars

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biologics and Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOLOGICS AND BIOSIMILARS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Biologics and Biosimilars Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Biologics and Biosimilars Sales Volume Forecast by Type (2018-2025)
11.3 United States Biologics and Biosimilars Sales Volume Forecast by Application (2018-2025)
11.4 United States Biologics and Biosimilars Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Biologics and Biosimilars
Figure United States Biologics and Biosimilars Market Size (K Units) by Type (2013-2025)
Figure United States Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure United States Biologics and Biosimilars Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Biologics and Biosimilars by Application in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Biologics and Biosimilars Market Size (Million USD) by Region (2013-2025)
Figure The West Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2025)
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Biologics and Biosimilars Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Biologics and Biosimilars Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Biologics and Biosimilars Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Biologics and Biosimilars Sales Share by Players/Suppliers
Figure 2017 United States Biologics and Biosimilars Sales Share by Players/Suppliers
Figure United States Biologics and Biosimilars Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Biologics and Biosimilars Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Biologics and Biosimilars Revenue Share by Players/Suppliers
Figure 2017 United States Biologics and Biosimilars Revenue Share by Players/Suppliers
Table United States Market Biologics and Biosimilars Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Biologics and Biosimilars Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Biologics and Biosimilars Market Share of Top 3 Players/Suppliers
Figure United States Biologics and Biosimilars Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Biologics and Biosimilars Product Category
Table United States Biologics and Biosimilars Sales (K Units) by Region (2013-2018)
Table United States Biologics and Biosimilars Sales Share by Region (2013-2018)
Figure United States Biologics and Biosimilars Sales Share by Region (2013-2018)
Figure United States Biologics and Biosimilars Sales Market Share by Region in 2017
Table United States Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Biologics and Biosimilars Revenue Share by Region (2013-2018)
Figure United States Biologics and Biosimilars Revenue Market Share by Region (2013-2018)
Figure United States Biologics and Biosimilars Revenue Market Share by Region in 2017
Table United States Biologics and Biosimilars Price (USD/Unit) by Region (2013-2018)
Table United States Biologics and Biosimilars Sales (K Units) by Type (2013-2018)
Table United States Biologics and Biosimilars Sales Share by Type (2013-2018)
Figure United States Biologics and Biosimilars Sales Share by Type (2013-2018)
Figure United States Biologics and Biosimilars Sales Market Share by Type in 2017
Table United States Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Biologics and Biosimilars Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2013-2018)
Figure Revenue Market Share of Biologics and Biosimilars by Type in 2017
Table United States Biologics and Biosimilars Price (USD/Unit) by Types (2013-2018)
Figure United States Biologics and Biosimilars Sales Growth Rate by Type (2013-2018)
Table United States Biologics and Biosimilars Sales (K Units) by Application (2013-2018)
Table United States Biologics and Biosimilars Sales Market Share by Application (2013-2018)
Figure United States Biologics and Biosimilars Sales Market Share by Application (2013-2018)
Figure United States Biologics and Biosimilars Sales Market Share by Application in 2017
Table United States Biologics and Biosimilars Sales Growth Rate by Application (2013-2018)
Figure United States Biologics and Biosimilars Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Pfizer Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Pfizer Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Roche Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Roche Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Amgen Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Amgen Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure AbbVie Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure AbbVie Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Sanofi Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Sanofi Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Novartis Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Novartis Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Merck Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Merck Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table Lilly Basic Information List
Table Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lilly Biologics and Biosimilars Sales Growth Rate (2013-2018)
Figure Lilly Biologics and Biosimilars Sales Market Share in United States (2013-2018)
Figure Lilly Biologics and Biosimilars Revenue Market Share in United States (2013-2018)
Table 3sbio Basic Information List
Table Changchun High Tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Sandoz Basic Information List
Table Teva Basic Information List
Table Hospira Basic Information List
Table Mylan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Players/Suppliers in 2017
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure United States Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Biologics and Biosimilars Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Type in 2025
Table United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Application in 2025
Table United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Biologics and Biosimilars Sales Volume Share Forecast by Region (2018-2025)
Figure United States Biologics and Biosimilars Sales Volume Share Forecast by Region (2018-2025)
Figure United States Biologics and Biosimilars Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories